Although multi-parametric radiomics has demonstrated promising results in accurately and sensitively predicting TERT mutations in gliomas, previous studies have primarily focused on grades 2–4 gliomas with limited investigation into GBM. This evidence concerns the gene TERT and central nervous system cancer.